Related Experiment Video
Updated: May 18, 2026
03:53
An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
Interferon-α for unresectable progressive and symptomatic plexiform neurofibromas
Rejin Kebudi1, Fatma B Cakir, Omer Gorgun
1Division of Pediatric Hematology-Oncology, Cerrahpaşa Medical Faculty, and Oncology Institute, Istanbul University, Istanbul, Turkey.
Journal of Pediatric Hematology/Oncology
|October 9, 2012
Summary
Neurofibromas, common in neurofibromatosis type-1, can cause pain and dysfunction. This study explores interferon-α 2a as a potential treatment for plexiform neurofibromas, showing promising results in some cases.
Area of Science:
- Oncology
- Genetics
- Neurology
Background:
- Neurofibromas are the primary manifestation of neurofibromatosis type-1 (NF1).
- Plexiform neurofibromas can lead to significant morbidity through nerve compression, pain, and functional deficits.
- Current treatment strategies for neurofibromas offer limited efficacy and unsatisfactory outcomes.
Observation:
- Presents four distinct cases of plexiform neurofibromas with varied clinical presentations.
- Includes an addendum detailing a patient with neurofibromatosis type-1 experiencing pain relief and tumor volume reduction.
- Highlights the therapeutic potential of interferon-α 2a in managing complex neurofibroma cases.
Findings:
- Interferon-α 2a demonstrated potential in alleviating pain associated with neurofibromas.
- Observed regression in tumor volume in a patient treated with interferon-α 2a.
- Case studies suggest interferon-α 2a may be a viable option for specific neurofibroma presentations.
Implications:
- Suggests interferon-α 2a as a potential therapeutic avenue for symptomatic neurofibromas.
- Calls for further research into the efficacy and optimal use of interferon-α 2a for neurofibromatosis type-1.
- May guide future treatment strategies for challenging plexiform neurofibroma cases.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...